Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease: Prospective, Randomized, Controlled Study

NCT00481364 is registered in ClinicalTrials.gov with Ercan OK as lead sponsor.

NCT NCT00481364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00481364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease: Prospective, Randomized, Controlled Study
Lead sponsor
Ercan OK
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2006
Completion date
December 31, 2008
Enrollment
446 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, dyslipidemia, inflammation, vascular calcification